SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000237
Filing Date
2016-11-22
Accepted
2016-11-22 17:14:46
Documents
4
Period of Report
2016-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201611228-kdoccn2.htm 8-K 34135
2 EXHIBIT 1.1 a201611228-kcn2ex11.htm EX-1.1 341199
3 EXHIBIT 5.1 a201611228-kcn2ex51.htm EX-5.1 18483
4 gibsondunnlogo.jpg GRAPHIC 11111
  Complete submission text file 0000882104-16-000237.txt   405106
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 162014045
SIC: 2836 Biological Products, (No Diagnostic Substances)